Current Mandate
Director and Regional Head, 2025 to present. Commercialization and institutional partnerships across advanced AI, biotechnology, and operational intelligence platforms in GCC markets.
META AGI ALLIANCE operates at the intersection of frontier technology and institutional adoption. Ashraf leads regional commercialization across a portfolio spanning AI drug discovery, enterprise agentic systems, biological data platforms, longevity technology, and operational intelligence.
Every portfolio company receives structured market access, regulatory alignment strategy, and introduction to Ashraf's 18-year institutional network across GCC markets.
Portfolio Companies
AI
Verseon AI
AI-driven drug discovery and molecular design. Translating computational biology into institutional healthcare adoption across GCC health systems.
Enterprise AI
Actiq AI
Enterprise-grade agentic AI systems. Governance-aligned commercialization within regulated enterprise environments.
BioTech
BioAro
Biological data platforms. Institutional adoption across research institutions and government health authorities.
Health
Biongevity
Longevity and healthspan technologies. GCC premium health sector market entry targeting sovereign-adjacent health institutions.
AI Ops
GenCut AI
Computer vision and operational intelligence. Industrial, logistics, and infrastructure sector commercialization.
PropTech
FlatINN
Asset optimization and rental operating systems across UAE residential markets. 30 to 40 percent higher net income for property owners across 800 plus units.
Get in Touch
Technology companies seeking GCC market entry or institutional adoption. Reach out to explore fit.
Inquiry Received.
Ashraf will respond if the context aligns.